The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma

被引:44
作者
Fukuda K. [1 ]
Tsujitani S. [1 ]
Maeta Y. [1 ]
Yamaguchi K. [1 ]
Ikeguchi M. [1 ]
Kaibara N. [1 ]
机构
[1] First Department of Surgery, Faculty of Medicine, Tottori University, Yonago 683-8504
关键词
Gastric carcinoma; Immunohistochemistry; Prognostic factor; RCAS1; Tumor infiltrating lymphocyte;
D O I
10.1007/s101200200038
中图分类号
学科分类号
摘要
Background. This study aimed to assess the prognostic value of receptor binding cancer antigen expressed on SiSo cells (RCAS1) expression and host immune response in gastric carcinomas. Methods. We investigated the relationship between RCAS1 expression, density of tumor-infiltrating lymphocytes (TIL), and clinicopathological findings in 129 patients with T3 gastric carcinoma who underwent curative surgery. Results. RCAS1 immunoreactivity was detected in the membrane and cytoplasm of tumor cells. Positive immunoreactivity for RCAS1 was detected in 70 patients (54.3%) and high expression levels of RCAS1 were found in 33 patients (25.6%). The expression of RCAS1 significantly correlated with the histological type of carcinoma and lymph node metastasis. Apoptotic rates in TILs showed marginally higher significance in patients with high RCAS1 expression than in those with low expression. The 5-year survival rates were 77.9% in patients with low RCAS1 expression and 48.4% in those with high RCAS1 expression. Although there was no significant difference in survival between the patients with marked and slight infiltration of TILs, frequent apoptosis in TILs indicated significantly worse prognosis. Patients with low RCAS1 expression survived significantly longer than those with high RCAS1 expression, as did those patients with a high rate of apoptosis in TILs. Multivariate analysis revealed that RCAS1 expression, as well as tumor size and lymph node metastasis, was an independent prognostic factor. Conclusions. The expression of RCAS1 was significantly correlated with poor prognosis in patients with T3 gastric carcinoma. RCAS1 protein may play an important role in the evasion of tumor cells from immunological defense mechanisms in human gastric carcinoma.
引用
收藏
页码:220 / 227
页数:7
相关论文
共 35 条
[21]  
Japanese classification of gastric carcinoma. 2nd English ed, Gastric Cancer, 1, pp. 10-24, (1998)
[22]  
Kubokawa M., Nakashima M., Yao T., Ito K., Harada N., Nawata H., Et al., Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer, Int J Oncol, 19, pp. 695-700, (2001)
[23]  
Takagi S., Chen K., Schwarz R., Iwatsuki S., Herbermann R.B., Whiteside T.L., Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2, Cancer, 63, pp. 102-111, (1989)
[24]  
Underwood J.C.E., Lymphoreticular infiltration in human tumors: Prognostic and biological implications, Br J Cancer, 30, pp. 537-548, (1974)
[25]  
Lipponen P.K., Eskelinen M.J., Jahiainen K., Harju E., Terho R., Tumor infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer, Eur J Cancer, 29, pp. 69-75, (1992)
[26]  
Nakano T., Oka K., Takahashi T., Morita S., Arai T., Roles of Langerhans' cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer, Cancer, 70, pp. 2839-2844, (1992)
[27]  
Van den Eyndel B.J., Van der Bruggen P., T-cell defined tumor antigens, Curr Opin Immunol, 9, pp. 684-693, (1997)
[28]  
Sahin U., Tureci O., Pfreundschuh M., Serological identification of human tumor antigens, Curr Opin Immunol, 9, pp. 709-716, (1997)
[29]  
Shichijo S., Nakao M., Imai Y., Takasu H., Kawamoto M., Niiya F., Et al., A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes, J Exp Med, 187, pp. 277-288, (1998)
[30]  
Runger T.M., Klein C.E., Becker J.C., Brocker E.B., The role of genetic instability, adhesion, cell mortality and immune escape mechanism in melanoma progression, Curr Opin Immunol, 6, pp. 188-196, (1994)